MT1-MMP prevents growth inhibition by three dimensional fibronectin matrix

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 503-508

  Takino, Takahisa ^a   Guo, Luyang ^a   Domoto, Takahiro ^a   Sato, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

ECM; Growth; Integrin; MT1 MMP; Tumor

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; GROWTH PROMOTOR; MATRIX METALLOPROTEINASE 14;

ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

3D; DMEM; DULBECCO'S MODIFIED EAGLE'S MEDIUM; ECM; ERK; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED KINASE; FIBRONECTIN; FN; GROWTH; INTEGRIN; MAPK; MATRIX METALLOPROTEINASE; MEMBRANE-TYPE 1 MMP; MITOGEN-ACTIVATED PROTEIN KINASE; MMP; MT1-MMP; PBS; PHOSPHATE-BUFFERED SALINE; PRB; RETINOBLASTOMA PROTEIN; SIRNA; SMALL INTERFERING RNA; THREE-DIMENSIONAL; TUMOR;

ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FIBRONECTINS; FIBROSARCOMA; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MATRIX METALLOPROTEINASE 14; RNA, SMALL INTERFERING; S PHASE;

EID: 84879884316     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.134     Document Type: Article

References (29)

1. Larsen M., Artym V.V., Green J.A., et al. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 2006, 18:463-471.
2. Cukierman E., Pankov R., Stevens D.R., et al. Taking cell-matrix adhesions to the third-dimension. Science 2001, 294:1708-1712.
3. Harunaga J.S., Yamada K.M. Cell-matrix adhesions in 3D. Matrix Biol. 2011, 30:363-368.
4. Keely P.J. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J. Mammary Gland Biol. Neoplasia 2011, 16:205-219.
5. Mizushima H., Wang X., Miyamoto S., et al. Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures. J. Cell Sci. 2009, 122:4277-4286.
6. Alexander N.R., Branch K.B., Parekh A., et al. Extracellular matrix rigidity promotes invadopodia activity. Curr. Biol. 2008, 18:1295-1299.
7. Serebriiskii I., Castello-Cros R., Lamb A., et al. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol. 2008, 27:573-585.
8. Sato H., Takino T., Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 2005, 96:212-217.
9. Sato H., Takino T., Okada Y., et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994, 370:61-65.
10. Deryugina E.I., Ratnikov B.I., Postnova T.I., et al. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 2002, 277:9749-9756.
11. Kajita M., Itoh Y., Chiba T., et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 2001, 153:893-904.
12. Endo K., Takino T., Miyamori H., et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 2003, 278:40764-40770.
13. Takino T., Miyamori H., Watanabe Y., et al. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res. 2004, 64:1044-1049.
14. Takino T., Watanabe Y., Matsui M., et al. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Exp. Cell Res. 2006, 312:1381-1389.
15. Takino T., Saeki H., Miyamori H., et al. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions. Cancer Res. 2007, 67:11621-11629.
16. McNiven M.A. Breaking away: matrix remodeling from the leading edge. Trends Cell Biol. 2013, 23:16-21.
17. Hotary K.B., Allen E., Punturieri A., et al. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 2000, 149:1309-1323.
18. Hotary K.B., Allen E.D., Brooks P.C., et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45.
19. Takino T., Tsuge H., Ozawa T. MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. Biochem. Biophys. Res. Commun. 2010, 396:1042-1047.
20. Schwarzbauer J.E., Sechler J.L. Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. Curr. Opin. Cell Biol. 1999, 11:622-627.
21. Wierzbicka-Patynowski I., Schwarzbauer J.E. The ins and outs of fibronectin matrix assembly. J. Cell Sci. 2003, 116:3269-3276.
22. Olden K., Yamada K.M. Mechanism of the decrease in the major cell surface protein of chick embryo fibroblasts after transformation. Cell 1977, 11:957-969.
23. Takino T., Nagao R., Manabe R., et al. Membrane-type 1 matrix metalloproteinase regulates fibronectin assembly to promote cell motility. FEBS Lett. 2011, 585:3378-3384.
24. Shi F., Sottile J. MT1-MMP regulates the turnover and endocytosis of ectracellualr matrix fibronectin. J. Cell Sci. 2011, 124:4039-4050.
25. Brenner K.A., Corbett S.A., Schwarzbauer J.E. Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene 2000, 19:3156-3163.
26. Henriet P., Zhong Z.D., Brooks P.C., et al. Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc. Natl. Acad. Sci. USA 2000, 97:10026-10031.
27. Wall S.J., Zhong Z.D., DeClerck Y.A. The cyclin-dependent kinase inhibitors p15INK4B and p21CIP1 are critical regulators of fibrillar collagen-induced tumor cell cycle arrest. J. Biol. Chem. 2007, 282:24471-24476.
28. Zutter M.M., Santoro S.A., Staatz W.D., et al. Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 1995, 92:7411-7415.
29. Butcher D.T., Alliston T., Weaver V.M. A tense situation: forcing tumor progression. Nat. Rev. Cancer 2009, 9:108-122.